-
-
-
-
-
-
-
Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022
-
-
-
-
-
-
-
ConforMIS (CFMS) Actera Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
-
-
-
-
-
-
-
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
-
-
-
-
-
-
-
ConforMIS Inc (CFMS) Appoints Gary Fischetti to its Board
-
-
-
-
-
-
-
ConforMIS Inc (CFMS) expects to report product revenue of approximately $15.3 million for the fourth quarter
-
-
-
-
-
-
-
Conformis Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

